- Home
- FBRX vs CLPR Comparison
FBRX vs CLPR Comparison
Compare FBRX & CLPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FBRX
- CLPR
- Stock Information
- Founded
- FBRX N/A
- CLPR 2015
- Country
- FBRX United States
- CLPR United States
- Employees
- FBRX N/A
- CLPR N/A
- Industry
- FBRX Biotechnology: Pharmaceutical Preparations
- CLPR Real Estate Investment Trusts
- Sector
- FBRX Health Care
- CLPR Real Estate
- Exchange
- FBRX Nasdaq
- CLPR Nasdaq
- Market Cap
- FBRX 76.1M
- CLPR 78.3M
- IPO Year
- FBRX N/A
- CLPR 2017
- Fundamental
- Price
- FBRX $10.98
- CLPR $4.46
- Analyst Decision
- FBRX Strong Buy
- CLPR Sell
- Analyst Count
- FBRX 4
- CLPR 2
- Target Price
- FBRX $77.58
- CLPR N/A
- AVG Volume (30 Days)
- FBRX 27.5K
- CLPR 90.1K
- Earning Date
- FBRX 03-17-2025
- CLPR 02-14-2025
- Dividend Yield
- FBRX N/A
- CLPR 8.97%
- EPS Growth
- FBRX N/A
- CLPR N/A
- EPS
- FBRX N/A
- CLPR N/A
- Revenue
- FBRX N/A
- CLPR $148,775,000.00
- Revenue This Year
- FBRX N/A
- CLPR N/A
- Revenue Next Year
- FBRX N/A
- CLPR N/A
- P/E Ratio
- FBRX N/A
- CLPR N/A
- Revenue Growth
- FBRX N/A
- CLPR 7.65
- 52 Week Low
- FBRX $4.11
- CLPR $3.38
- 52 Week High
- FBRX $28.68
- CLPR $7.12
- Technical
- Relative Strength Index (RSI)
- FBRX 36.53
- CLPR 54.29
- Support Level
- FBRX $9.81
- CLPR $3.86
- Resistance Level
- FBRX $13.13
- CLPR $5.16
- Average True Range (ATR)
- FBRX 1.52
- CLPR 0.29
- MACD
- FBRX -0.08
- CLPR 0.11
- Stochastic Oscillator
- FBRX 18.17
- CLPR 46.15
About FBRX Forte Biosciences Inc.
Forte Biosciences Inc is a biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary therapeutic molecule with potentially broad autoimmune applications in such indications as graft-versus-host disease (GvHD), vitiligo, and alopecia areata (AA).
About CLPR Clipper Realty Inc.
Clipper Realty Inc is a self-administered and self-managed real estate company. It acquires, owns, manages, operates, and repositions multifamily residential and commercial properties in the New York metropolitan area, with a portfolio in Manhattan and Brooklyn. It has classified its reporting segments into Residential Rental Properties and Commercial Rental Properties. The company derives its revenue mostly from the Residential segment.